• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Amuse Incorporated

  • ID: 637019
  • April 2015
  • 38 Pages
  • Wright Investors Service

A textual analysis of the financial results for Amuse Incorporated compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Amuse Incorporated. There is a textual review of the financial results of Amuse Incorporated versus Daibiru Corp, Orix Jreit Inc and Japan Prime Realty Investment Corporation. The comparative analysis of these companies compares Sales (sales, sales growth and READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

TMS Entertainment Ltd., Toei Animation Company Limited and Sotsu Company Limited

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Daibiru Corp - Product Thumbnail Image

    Daibiru Corp

    • Language: English
    • 39 Pages
    • Published: February 2015
    FROM
  • Tohokushinsha Film Corp - Product Thumbnail Image

    Tohokushinsha Film Corp

    • Language: English
    • 54 Pages
    • Published: February 2015
    FROM
  • IG Port Incorporated - Product Thumbnail Image

    IG Port Incorporated

    • Language: English
    • 54 Pages
    • Published: February 2015
    FROM
  • Amuse Acquisition Manual - Product Thumbnail Image Amuse Acquisition Manual

    Amuse Acquisition Manual

    • Language: English
    • Published: May 2015
  • Sotsu Company Limited - Product Thumbnail Image

    Sotsu Company Limited

    • Language: English
    • 54 Pages
    • Published: April 2015
    FROM
  • Toei Animation Company Limited - Product Thumbnail Image

    Toei Animation Company Limited

    • Language: English
    • 54 Pages
    • Published: May 2015
    FROM
  • IGB Corporation Berhad - Product Thumbnail Image

    IGB Corporation Berhad

    • Language: English
    • 37 Pages
    • Published: April 2015
    FROM
  • Toei Co Ltd - Product Thumbnail Image

    Toei Co Ltd

    • Language: English
    • 54 Pages
    • Published: April 2015
    FROM
  • Orix Jreit Inc - Product Thumbnail Image

    Orix Jreit Inc

    • Language: English
    • 34 Pages
    • Published: April 2015
    FROM
  • Media Nusantara Citra Tbk PT - Product Thumbnail Image

    Media Nusantara Citra Tbk PT

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.